1:2:1 Podcast

Aspirin reduces risk of melanoma in women

Aspirin can check off one more box when it comes to prevention – a new study has found that women who took aspirin on a regular basis reduced their risk of developing melanoma by an average of 21 percent. The drug has already been shown to have protective effects on cardiovascular disease and colorectal cancer in women, so these findings may play a more important role in strategies for preventing other kinds of cancer. In this podcast, Stanford dermatologist Jean Tang, MD, PhD, discusses the study and why, despite the promising results, she's not ready to say that an aspirin a day will keep melanomas away.

Length: 17 mins. 52 sec.

Leading the Biomedical Revolution

We are in the middle of a biomedical revolution more profound and far-reaching than the industrial and digital revolutions that made it possible.

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.